| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $12.6M | -32.2% |
| Cost of Revenue | $8.6M | -28.5% |
| Gross Profit | $4.0M | -39.1% |
| R&D Expense | $125K | -77.5% |
| SG&A Expense | $9.8M | +3.2% |
| Operating Income | -$5.9M | -70.7% |
| Pre-tax Income | -$5.4M | -38.9% |
| Income Tax | -$332K | -146.6% |
| Net Income | -$5.1M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.4M | +75.3% |
| Accounts Receivable | $2.4M | -14.2% |
| Inventory | $2.7M | +5.3% |
| Current Assets | $16.4M | +26.6% |
| Total Assets | $18.8M | +25.7% |
| Current Liabilities | $5.8M | +42.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.2M | -25.8% |
| Capital Expenditures | $137K | -23.5% |
| Investing Cash Flow | -$99K | -125.5% |
| Financing Cash Flow | $7.4M | +123.6% |
| Free Cash Flow | -$4.4M | -23.3% |
| -28.8% |
| Total Liabilities |
| $10.1M |
| +5.4% |
| Stockholders' Equity | $8.7M | +62.2% |